Evidence map›Paper›PMID 42839049›Full record

ArticleNature biotechnology2026

Highly multiplexed mammalian metabolic engineering with a shotgun approach.

Julie Trolle, Sofia Sessa, Aleksandra Wudzinska, Mark Grivainis, Katerina Rincones, Tori Rodrick, Drew R Jones, David Fenyö, Sudarshan Pinglay, Jef D Boeke

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julie TrolleInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0002-2497-3531
Sofia SessaInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Aleksandra WudzinskaInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
Mark GrivainisInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0001-8156-7153
Katerina RinconesGraduate Program in Molecular Engineering, University of Washington, Seattle, WA, USA.
Tori RodrickDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0009-0006-6201-6579
Drew R JonesDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.
David FenyöInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0001-5049-3825
Sudarshan PinglayInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA. pinglay@uw.edu.ORCID http://orcid.org/0000-0002-8781-1476
Jef D BoekeInstitute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY, USA. jef.boeke@nyulangone.org.ORCID http://orcid.org/0000-0001-5322-4946

Funding

Dissecting the logic of mammalian gene regulation using synthetic biology and single-cell sequencingDP5OD036167 · OD · UNIVERSITY OF WASHINGTON · PI Sudarshan Pinglay · 2023 to 2026
$1.9M
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) RM1-HG009491U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) DP5OD036167
6 · The paper itself

Abstract

Mammalian metabolic engineering advances basic biology, bioproduction and cell therapy. However, as pathway complexity increases, so does the size of the combinatorial design space and required DNA constructs, rendering unbiased screens intractable. Here, we developed shotgun genetic engineering (SGE), which exploits the ease of delivering many barcoded small constructs-rather than a single large one-into mammalian cells. Each cell serves as an independent experiment, carrying a synthetic pathway that explores gene content, stoichiometry and organellar localization. Functional pathways are identified by sequencing barcodes from cells exhibiting the desired phenotype. Using SGE, we screened millions of pathway combinations to engineer essential amino acid biosynthesis, achieving near-wild-type growth without valine and enabling isoleucine-free growth in Chinese hamster ovary cells, as well as valine-free growth in Jurkat cells. Functional pathways favored mitochondrial localization and required the integration of tens of kilobases of synthetic DNA, beyond the scale of conventional screening. The resulting datasets support machine-learning-guided decoding and engineering of complex biosynthetic traits in mammalian systems.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.